Navigation Links
Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Date:8/6/2012

s 62 Hepatitis B Therapeutics - Introduction 72.1 Overview 72.2 Epidemiology 82.3 Disease Burden 102.4 Etiology 112.5 Symptoms 132.6 Diagnosis 132.7 Pathophysiology 162.8 Treatment and Management Pattern 192.9 GlobalData Pipeline Report Guidance 223 Hepatitis B Therapeutics - Market Characterization 233.1 Hepatitis B Therapeutics Market Size (2006 - 2011) - Global 233.2 Hepatitis B Therapeutics Market Forecast (2011 - 2019) - Global 243.3 Hepatitis B Therapeutics Market Size (2006 - 2011) - The US 253.4 Hepatitis B Therapeutics Market Forecast (2011 - 2019) - The US 263.5 Hepatitis B Therapeutics Market Size (2006 - 2011) - France 273.6 Hepatitis B Therapeutics Market Forecast (2011 - 2019) - France 283.7 Hepatitis B Therapeutics Market Size (2006 - 2011) - Germany 293.8 Hepatitis B Therapeutics Market Forecast (2011 - 2019) - Germany 303.9 Hepatitis B Therapeutics Market Size (2006 - 2011) - Italy 313.10 Hepatitis B Therapeutics Market Forecast (2011 - 2019) - Italy 323.11 Hepatitis B Therapeutics Market Size (2006 - 2011) - Spain 333.12 Hepatitis B Therapeutics Market Forecast (2011 - 2019) - Spain 343.13 Hepatitis B Therapeutics Market Size (2006 - 2011) - The UK 353.14 Hepatitis B Therapeutics Market Forecast (2011 - 2019) - The UK 363.15 Hepatitis B Therapeutics Market Size (2006 - 2011) - Japan 373.16 Hepatitis B Therapeutics Market Forecast (2011 - 2019) - Japan 383.17 Drivers and Barriers for the Hepatitis B Therapeutics Market 393.17.1 Drivers for the Hepatitis B Therapeutics Market 393.17.2 Barriers for the Hepatitis B Therapeutics Market 393.18 Opportunity and Unmet Need 403.19 Key Takeaway 414 Hepatitis B Therapeutics - Competitive Assessment 424.1 Overview 424.2 Strategic Competitor Assessment 424.3 Product Profile for the Major Marketed Drugs 434.3.1 Intron A (interferon alpha 2b) 434.3.2 Pegasys (peginterferon alfa-2a) 444.3.3 Baraclude (entecavir) 454.3.4 Tyzeka (telbivudine) 474.3.5 Hepsera (adevofir) 504.3.6 Epivir-HBV (lamivudine) 524.3.7 Viread (
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Celltex Therapeutics Corporation Expands Laboratory Operations And Adds Depth To Its Management Team
2. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
3. Cell Therapeutics, Inc. (CTI) to Report Second Quarter Financial Results on August 1
4. United Therapeutics Corporation Reports Second Quarter 2012 Financial Results
5. Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
6. United Therapeutics Corporation to Announce Second Quarter 2012 Financial Results Before Market Open on Thursday, July 26, 2012
7. Juventas Therapeutics Raises $22.2 Million Series B Financing
8. Silence Therapeutics Announces Subscription and Open Offer to Raise up to £5.7 Million
9. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
10. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
11. Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 Quincy Bioscience, ... and development of calcium-binding proteins to support healthy ... safety assessment study of apoaequorin in ... published for the British Industrial Biological Research Association. ... to investigate potential adverse effects, if any, of ...
(Date:5/23/2013)... ELMSFORD, N.Y. , May 23, 2013  BioScrip, ... the Company will present at the Jefferies 2013 Global ... the Grand Hyatt New York. ... and Hai Tran , Chief Financial ... 11:30 a.m. Eastern Daylight Time.   About ...
(Date:5/23/2013)... SCHOFIELD, Wis. , May 23, 2013 /PRNewswire/ ... a researcher, developer, and marketer of over-the-counter (OTC) ... re-issued its research opinion on the company based ... Highlights , Non-Prescription, All Natural Product ... Show the Product Outperforms #1 Prescription Competitor ...
(Date:5/23/2013)... SAN MARINO, Calif. , May 23, 2013 ... announces today a strategic alliance with DAK Renewable ... increase the corn oil yield. VG Energy is ... Inc. (OTC Pink: VGLS). VG Energy,s ... pathways to increase the oil yield in plants, ...
Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3
... - First ... Mass., April 24 Caliper Life,Sciences, Inc. (Nasdaq: ... for,drug discovery and life sciences research, today reported it ... operations to,reduce overall facility costs and improve productivity and ...
... N.J., April 24 Amicus Therapeutics,Inc. (Nasdaq: FOLD ... Executive Officer, will present a corporate update at the ... at 2:20 p.m. EDT, at the Ritz-Carlton in Key ... and may be accessed by visiting,Amicus, website at ...
... CEPH ) today announced its receipt of ... Abbreviated New Drug Application (ANDA),submitted to the U.S. ... requesting approval to market and sell a generic,version ... Notice,Letter, Watson alleges that the U.S. Patent Numbers ...
Cached Biology Technology:Caliper Life Sciences Reports West Coast Consolidation of Operations 2Caliper Life Sciences Reports West Coast Consolidation of Operations 3Caliper Life Sciences Reports West Coast Consolidation of Operations 4Cephalon Notified of Generic Fentanyl Buccal Tablet Filing 2Cephalon Notified of Generic Fentanyl Buccal Tablet Filing 3
(Date:5/22/2013)... U.S. Forest Service scientists are part of "Landscapes ... the TKF Foundation, will examine how collaborative planning and ... from tragedy. , The TKF Foundation announced today that ... for grant funding. In addition to research on the ... and resiliency, the 3-year, $585,000 grant will contribute to ...
(Date:5/22/2013)... durability in fuel cell powered buses, including a ... between electrode degradation processes and bus membrane durability. ... electrode degradation stressors in the operating cycle of ... findings of the study, led by SFU graduate ... long-term study at Burnaby-based Ballard Power Systems and ...
(Date:5/22/2013)... engineers must join together in a major new effort ... crisis in providing Earth,s people with clean water that ... of a comment article in the current edition of ... of the American Chemical Society (ACS), the world,s largest ... Sedlak, Ph.D., and Jerald L. Schnoor, Ph.D., explain that ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2Tests lead to doubling of fuel cell life 2
... gaining popularity in the United States, where health-conscious consumers ... According to the U.S. Department of Agriculture, per capita ... and the value of the U.S. sweetpotato crop in ... sweetpotato crops are high, requiring that commercial growers optimize ...
... redwood and take a sample from the top and bottom ... are different. Christopher A. Cullis, chair of biology at ... of his controversial research findings. Cullis, who has spent ... (Linum usitatissimum), has found that the environment not only weeds ...
... This release is available in German . ... recently discovered in weevils. The hip of Trigonopterus oblongus ... on a screw-and-nut system. This first biological screw thread is about ... synchrotron radiation. The discovery is reported by the current issue of ...
Cached Biology News:Sweetpotato foundation seed tested in commercial operations 2Environs prompt advantageous gene mutations as plants grow; changes passed to progeny 2Environs prompt advantageous gene mutations as plants grow; changes passed to progeny 3Karlsruhe Institute of Technology: Nature uses screws and nuts 2
Recombinant Equine TNF-alpha/TNFSF1A, CF...
GRADIENT MAKER, 30 ML, 1 EA. Category: Protein Vertical Instruments....
DALT GRADIENT MAKER,230V, 1 EA. Category: 2D DALT Systems....
Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is ...
Biology Products: